专家：警惕“懒癌”潜在风险 推动甲状腺疾病诊疗智能化、精准化

Core Insights - The second China Research Hospital Association Thyroid Disease Professional Committee's academic exchange and the sixth Guangxi-Thailand Thyroid Academic Exchange Conference were held in Guangzhou, highlighting advancements in thyroid tumor diagnosis and treatment [1] Group 1: Treatment Advances - Thyroid tumors have seen significant breakthroughs in diagnosis and treatment, but experts emphasize the importance of standardized treatment to ensure efficacy [1] - The most common malignant thyroid tumor is papillary thyroid carcinoma, often referred to as "lazy cancer" due to its slow progression and favorable prognosis [1] - However, experts warn against complacency, as anaplastic thyroid carcinoma is highly aggressive and often diagnosed at an advanced stage [1] Group 2: Surgical Techniques - Surgical intervention remains the preferred and potentially curative treatment for thyroid cancer, particularly in early-stage patients, where standardized surgery can enhance cure rates [1] - The conference discussed the critical role of fine needle aspiration biopsy in preoperative diagnosis, allowing for more accurate tumor characterization and personalized surgical plans [2] Group 3: Technological Integration - The application of artificial intelligence in preoperative planning, intraoperative navigation, pathological diagnosis, and postoperative follow-up is a key discussion point, aiming to enhance precision in thyroid surgery [2] - Robotic surgery, combined with AI, is beginning to integrate into thyroid tumor treatment, offering precise operations and the potential to improve access to care in remote areas [2] Group 4: Public Awareness and Education - There is a call for collective efforts to improve public understanding of thyroid cancer, including prevention, treatment knowledge, and postoperative care [2] - A new book titled "Hundred Questions and Answers on Thyroid Diseases" is planned to provide authoritative and accessible health guidance for patients [2]